A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

4.9K views

⸱

DOI:

10.3791/61003

⸱

May 31st, 2020

 ,  ,  ,  , 

In This Article

Summary

Here we describe a method for retroviral overexpression and adoptive transfer of murine B-1a cells to examine in vivo B-1a cell migration and localization. This protocol can be extended for diverse downstream functional assays including quantification of donor B-1a cell localization or analysis of donor cell-derived secreted factors post-adoptive transfer.

Abstract

As cell function is influenced by niche-specific factors in the cellular microenvironment, methods to dissect cell localization and migration can provide further insight on cell function. B-1a cells are a unique B cell subset in mice that produce protective natural IgM antibodies against oxidation-specific epitopes that arise during health and disease. B-1a cell IgM production differs depending on B-1a cell location, and therefore it becomes useful from a therapeutic standpoint to target B-1a localization to niches supportive of high antibody production. Here we describe a method to target B-1a cell migration to the bone marrow by retroviral-mediated overexpression of the C-X-C motif chemokine receptor 4 (CXCR4). Gene induction in primary murine B cells can be challenging and typically yields low transfection efficiencies of 10-20% depending on technique. Here we demonstrate that retroviral transduction of primary murine B-1a cells results in 30-40% transduction efficiency. This method utilizes adoptive cell transfer of transduced B-1a cells into B cell-deficient recipient mice so that donor B-1a cell migration and localization can be visualized. This protocol can be modified for other retroviral constructs and can be used in diverse functional assays post-adoptive transfer, including analysis of donor cell or host cell phenotype and function, or analysis of soluble factors secreted post B-1a cell transfer. The use of distinct donor and recipient mice differentiated by CD45.1 and CD45.2 allotype and the presence of a GFP reporter within the retroviral plasmid could also enable detection of donor cells in other, immune-sufficient mouse models containing endogenous B cell populations.

Introduction

Recent studies have demonstrated considerable immune cell, and specifically B cell, phenotypic and functional heterogeneity depending on cell localization1,2,3,4,5. B-1a cells are one such population with heterogeneous capacity to produce protective IgM antibodies; bone marrow B-1a cells secrete IgM constitutively and contribute significantly to plasma IgM titers6, while peritoneal B-1a cells have low-level IgM secretion at homeostasis and instead can be activated through innate toll....

Access restricted. Please log in or start a trial to view this content.

Protocol

All animal protocols were approved by the Animal Care and Use Committee at the University of Virginia.

1. Magnetic separation and enrichment of peritoneal B-1 cells

  1. Euthanize a 12−14-week-old, male, CD45.1+ApoE-/- mouse using CO2.
  2. Make a superficial cut in the abdomen using straight surgical scissors and peel back skin using curved scissors to expose the peritoneal wall. Flush peritoneal cavity with 10 mL of 37 °C RPMI-1640 medium using a 10 mL syringe and 25 G needle. Shake mouse to disengage cells by grasping the tail and moving the mouse side to side thoroughly for 15ͨ....

Access restricted. Please log in or start a trial to view this content.

Results

An overview of the protocol is given in Figure 1. Figure 2 displays enrichment of peritoneal B-1a cells after magnetic depletion of other peritoneal cell types. Live singlet cells in the post-depletion fraction have a greater proportion of CD19+ B cells compared to F4/80+ macrophages, lack CD5hi CD19- T cells, and contain an increased frequency of CD19+ CD5mid B-1a cells compared to the pre-depletion fractio.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The method provided here enables stable and relatively efficient primary B-1a cell gene delivery, in vivo adoptive transfer, and identification and localization of injected cells. Cells were able to be detected 17 weeks post-cell transfer and retained increased CXCR4 expression. Retrovirus-mediated delivery yielded 30-40% transduction efficiency of primary murine B-1a cells with minimal impact on cell viability in our hands (Figure 4e). This is in line with results from a previous study by M.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by 1R01 HL107490, 1R01 HL136098, Project 3 of P01 HL055798, P01 HL136275-01 (C.A. McNamara), and R01GM100776 (T.P. Bender). A. Upadhye was supported by American Heart Association Pre-doctoral fellowship 16PRE30300002 and 5T32AI007496-20. We thank Joanne Lannigan, Mike Solga, and Claude Chew from the University of Virginia Flow Cytometry Core for their excellent technical assistance.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
70 micron filter capsFalcon352235
anti-biotin microbeadsMiltenyi Biotec130-090-485
anti-CD16/CD32, or Fc blockLife TechnologiesMFCR00
B220 APCeBioscience17-0452-83Clone: RA3-6B2
Beta-mercaptoethanolGibco21985-023
CD19 APCef780eBioscience47-0193-82Clone: eBio1D3
CD23 biotineBioscience13-0232-81Clone: B3B4
CD23 PECy7eBioscience25-0232-82Clone: B3B4
CD3e biotineBioscience13-0033-85Clone: eBio500A2
CD45.1 ApoE-/- miceN/AN/ABred in house
CD45.1 PerCP-Cy5.5BD Biosciences560580Clone: A20
CD45.2 BV421BD Biosciences562895Clone: 104
CD45.2 Rag1-/- ApoE-/- miceN/AN/ABred in house
CD5 PEeBioscience12-0051-83Clone: 53-7.3
Ctl-GFP retrovirusN/AN/AGenerated in house using GFP-expressing retroviral plasmid MigR1 provided by Dr. T.P. Bender
CXCR4 APCeBioscience17-9991-82Clone: 2B11
CXCR4-GFP retrovirusN/AN/AGenerated in house by cloning mouse CXCR4 into MigR1 retroviral plasmid
F4/80 biotinLife TechnologiesMF48015Clone: BM8
Flowjo Software v. 9.9.6Treestar Inc.License required
GentamicinGibco15710-064
Gr-1 biotineBioscience13-5931-82Clone: RB6-8C5
heat-inactivated fetal bovine serumGibco16000-044
HEPESGibco15630-080
IgM PECF594BD Biosciences562565Clone: R6-60.2
Insulin syringesBD Biosciences329461
IsofluraneHenry Schein Animal Health029405
Live/Dead YellowLife TechnologiesL34968
LS columnsMiltenyi Biotec130-042-401
NK1.1 biotinBD Biosciences553163Clone: PK136
Non-essential amino acidsGibco11140-050
ODN 1668InvivoGentlrl-1668
PBSGibco14190-144
RPMI-1640Gibco11875-093
Sodium pyruvateGibco11360-070
Ter119 biotineBioscience13-5921-82Clone: Ter119

References

  1. Baumgarth, N. B-1 Cell Heterogeneity and the Regulation of Natural and Antigen-Induced IgM Production. Frontiers in Immunology. 7, 324(2016).
  2. Holodick, N. E., Vizconde, T., Rothstein, T. L.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

CXCR4 ExpressionAdoptive Cell TransferBone Marrow LocalizationPeritoneal Fluid HarvestingMagnetic Cell SortingTLR9 Agonist StimulationCD45 Allotype Detection